COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 70 filers reported holding COGENT BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45,670,628 | -17.7% | 4,684,167 | +0.0% | 4.81% | -45.8% |
| Q2 2023 | $55,460,123 | +5.2% | 4,684,132 | -4.1% | 8.87% | -13.8% |
| Q1 2023 | $52,708,902 | +12.9% | 4,884,977 | +21.0% | 10.29% | +30.9% |
| Q4 2022 | $46,680,633 | -22.5% | 4,038,117 | 0.0% | 7.86% | -15.4% |
| Q3 2022 | $60,249,000 | +65.4% | 4,038,117 | 0.0% | 9.30% | +29.6% |
| Q2 2022 | $36,424,000 | +346.6% | 4,038,117 | +270.9% | 7.17% | +443.0% |
| Q1 2022 | $8,155,000 | -12.7% | 1,088,817 | 0.0% | 1.32% | +3.4% |
| Q4 2021 | $9,342,000 | +2.0% | 1,088,817 | 0.0% | 1.28% | +8.6% |
| Q3 2021 | $9,157,000 | +3.7% | 1,088,817 | 0.0% | 1.18% | +9.8% |
| Q2 2021 | $8,830,000 | -7.6% | 1,088,817 | 0.0% | 1.07% | +3.3% |
| Q1 2021 | $9,560,000 | -21.8% | 1,088,817 | 0.0% | 1.04% | -42.3% |
| Q4 2020 | $12,227,000 | – | 1,088,817 | – | 1.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,038,117 | $46,680,633 | 7.86% |
| COMMODORE CAPITAL LP | 4,319,940 | $49,939 | 7.53% |
| TCG Crossover Management, LLC | 3,631,042 | $41,974,846 | 7.41% |
| Fairmount Funds Management LLC | 2,758,975 | $31,893,751 | 5.06% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $5,797,687 | 4.20% |
| Ghost Tree Capital, LLC | 800,000 | $9,248,000 | 3.95% |
| Vivo Capital, LLC | 1,994,941 | $23,062 | 2.66% |
| 5AM Venture Management, LLC | 790,440 | $9,137,486 | 2.46% |
| Frazier Life Sciences Management, L.P. | 2,109,154 | $24,381,820 | 1.52% |
| Logos Global Management LP | 1,100,000 | $12,716,000 | 1.49% |